HLA-A*11:01 is associated with levetiracetam-induced psychiatric adverse events

Levetiracetam (LEV) is effective for focal and generalized epilepsy and is used worldwide because of its relatively few drug interactions and favorable tolerability. However, some psychiatric adverse events (PAEs) have been reported, resulting in drug withdrawal. The pathophysiology of LEV-induced P...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Tae-Won, Moon, Jangsup, Kim, Tae-Joon, Jun, Jin-Sun, Lim, Jung-Ah, Lee, Soon-Tae, Jung, Keun-Hwa, Park, Kyung-Il, Jung, Ki-Young, Chu, Kon, Lee, Sang Kun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6051654/
https://www.ncbi.nlm.nih.gov/pubmed/30020991
http://dx.doi.org/10.1371/journal.pone.0200812

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6051654/
https://www.ncbi.nlm.nih.gov/pubmed/30020991
http://dx.doi.org/10.1371/journal.pone.0200812

Ejemplares similares